You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022

Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • La Jolla, California
  • +4 more
Aug 9, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Glioma, Cholangiocarcinoma, Chondrosarcoma Trial in Amsterdam, Leiden (Metformin and chloroquine combination)

Completed
  • Glioma
  • +2 more
  • Metformin and chloroquine combination
  • Amsterdam, Noord-Holland, Netherlands
  • +2 more
Jan 7, 2020

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting
  • Resectable Cholangiocarcinoma
  • +5 more
  • Atlanta, Georgia
  • +6 more
Oct 5, 2022

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

Cholangiocarcinoma With IDH1 Mutation, Solid Tumors With IDH1 Mutation Trial in Beijing (AB-218 capsule)

Not yet recruiting
  • Cholangiocarcinoma With IDH1 Mutation
  • Solid Tumors With IDH1 Mutation
  • AB-218 capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Apr 2, 2023

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

/or PD-1 Inhibitors for Unresectable Intrahepatic

Completed
  • Intrahepatic Cholangiocarcinoma
  • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 7, 2022

Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

Recruiting
  • Liver and Intrahepatic Bile Duct Carcinoma
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 11, 2022

Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
Jun 2, 2022

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Cholangiocarcinoma, Intrahepatic Trial in Toronto (Liver Transplantation)

Enrolling by invitation
  • Cholangiocarcinoma, Intrahepatic
  • Liver Transplantation
  • Toronto, Ontario, Canada
    University Health Network
Apr 8, 2022

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Transcatheter arterial chemoembolization
  • +3 more
  • (no location specified)
Feb 17, 2022

Predict Efficacy of GC in Treatment of Intrahepatic

Not yet recruiting
  • Organoids
  • Intrahepatic Cholangiocarcinoma
  • gemcitabine + cisplatin
  • (no location specified)
Nov 30, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Li Xu
Dec 8, 2021

Intrahepatic Cholangiocarcinoma Trial (DEB-TACE combined with Surufatinib and Camrelizumab)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • DEB-TACE combined with Surufatinib and Camrelizumab
  • (no location specified)
Feb 9, 2022

Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 4, 2022

Intrahepatic Cholangiocarcinoma Trial in China, United States (Extend LymphAdenectomy)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Extend LymphAdenectomy
  • Baltimore, Maryland
  • +12 more
Nov 7, 2022

Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib Trial in Shanghai (Neoadjuvant treatment)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • Neoadjuvant treatment
  • Shanghai, Shanghai, China
    Zhongshan hospital
Jul 5, 2021